Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
0.92
-0.01 (-1.47%)
At close: Oct 03, 2025, 3:59 PM
0.90
-1.75%
After-hours: Oct 03, 2025, 06:52 PM EDT
Akari Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.9M | -3.71M | -3.77M | -2.9M | -7.56M | -5.57M | -3.5K | -3.5K | -3M | 1M | -3.45K | -3.45K | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.84M |
Depreciation & Amortization | n/a | n/a | 1K | n/a | n/a | 13K | 1.07 | 1.07 | 1.85K | 1K | 1.03 | 1.03 | 942.00 | 1.01K | 1.01K | 1.03K | 1.05K | 1.03K |
Stock-Based Compensation | 719K | 1.01M | 1.26M | 988.26K | 445.00 | 296.00 | 304.24 | 304.24 | 270.76 | 265.00 | 256.65 | 256.65 | 122.86K | 98.84K | 77.05K | 70.61K | 82.1K | 84.89K |
Other Working Capital | -416K | 567K | 1.54M | 1.35M | 564.00 | 1.6M | 534.00 | 534.00 | -499K | -563K | 2.2K | 2.2K | -2.96M | 109.3K | 898.21K | -177.73K | -531.65K | -1.93M |
Other Non-Cash Items | -1.66M | -27K | -1.15M | 2.02M | 2.66M | -63K | -763.77 | -763.77 | -3.06M | -5.32M | -2.96K | -2.96K | -54.14K | -82.36K | 49.21K | -1.33K | -70.86K | 265.48K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -416K | 567K | 1.54M | -1.6M | 564.00 | 1.6M | 534.00 | 534.00 | -918.63K | -563K | 2.2K | 2.2K | -2.96M | 109.3K | 656.9K | -177.73K | -531.65K | -1.93M |
Operating Cash Flow | -3.26M | -2.15M | -2.12M | -1.49M | -4.89M | -4.04M | -3.43K | -3.43K | -9.57M | -4.88M | -3.94K | -3.94K | -8.57M | -5.05M | -5M | -1.56M | -4.87M | -7.42M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.16 | -10.7K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -214K | -514K | -973K | -336K | 669K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -727K | 1.09M | -1K | 26K | n/a | -212K | 1.76K | 1.76K | 3.21M | 3.21M | 6.46M | 6.46M | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.38M | 2.13M | 2.15M | -443K | 7.76M | 1.51M | 1.76K | 1.76K | 3.5M | 3.21M | 6.46K | 6.46K | n/a | 12.37M | 1.12M | 11.18M | 1.99M | n/a |
Net Cash Flow | 129K | -17K | 413K | -1.93M | 2.87M | 1.31M | -1.67M | -1.67M | 7.17M | -8.14M | 2.55M | 8.13M | -8.57M | 7.36M | -4.03M | 9.6M | -2.88M | -7.39M |
Free Cash Flow | -3.26M | -2.15M | -2.12M | -1.49M | -4.89M | -4.04M | -3.43K | -3.43K | -9.57M | -4.88M | -3.94K | -3.94K | -8.57M | -5.05M | -5M | -1.56M | -4.87M | -7.42M |